Margaret McLoughlin is a director of Quince Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Aug 23 | QNCX Quince Therapeutics | Common Stock | Buy | Acquire P | No | No | 1.23 | 8,000 | 9.84 k | 8,000 |
24 May 23 | QNCX Quince Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.58 | 27,000 | 42.66 k | 27,000 |